Provenzano, E., Vallier, A. -L., Champ, R., Walland, K., Bowden, S. (Sarah), Grier, Anna, Fenwick, Nicola, Abraham, J. (Janet), Iddawela, M., Caldas, C., Hiller, Louise, Dunn, Janet A. and Earl, Helena M.. (2013) A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial. British Journal of Cancer, Volume 108 (Number 4). pp. 866-872. ISSN 0007-0920

Hiller, Louise, Dunn, Janet A., Higgins, Helen B., Ogburn-Storey, Emma, Loi, Shrushma, Vallier, Anne-Laure and Earl, Helena M.. (2011) Optimising patient recall of adverse events over prolonged time periods. Trials, Vol.12 (Suppl.1). A74. ISSN 1745-6215

Campbell, H. E., Epstein, D., Bloomfield, D., Griffin, S., Manca, A., Yarnold, J., Bliss, J., Johnson, L., Earl, H., Poole, Christopher, Hiller, Louise, Dunn, Janet A., Hopwood, P., Barrett-Lee, P., Ellis, P., Cameron, D., Harris, A. L., Gray, A. M. and Sculpher, Mark J.. (2011) The cost-effectiveness of adjuvant chemotherapy for early breast cancer : a comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses. European Journal of Cancer, Vol.47 (No.17). pp. 2517-2530. ISSN 0959-8049

Gounaris, I., Sinnatamby, R., Taylor, K., Wallis, M., Hiller, Louise, Vallier, A.-L., Provenzano, E., Iddawela, M., Wishart, G., Earl, H. and Britton, P. (2010) O-31 Accuracy of unidimensional and volumetric ultrasound measurements in predicting good pathological response to neoadjuvant chemotherapy in breast cancer patient. In: 1st British Breast Cancer Research Conference, Nottingham, England, 15-17 Sep 2010. Published in: European Journal of Cancer Supplements, Vol.8 (No.6). p. 12.

. (2010) Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter. Journal of Clinical Investigation, Vol.120 (No.8). pp. 2842-2857. ISSN 0021-9738

Bartlett, John M. S., Munro, Alison F., Dunn, Janet A., McConkey, Christopher C., Jordan, S., Twelves, Chris, Cameron, D. (David), 1956-, Thomas, Jeremy St. J., Campbell, Fiona M., Rea, Daniel W., Provenzano, Elena, Caldas, Carlos, Pharaoh, Paul, Hiller, Louise, Earl, Helena M. and Poole, Christopher. (2010) Predictive markers of anthracycline benefit : a prospectively planned analysis of the UK national epirubicin adjuvant trial (NEAT/BR9601). Lancet Oncology, Vol.11 (No.3). pp. 266-274. ISSN 1470-2045

Nicholson, Linda J., Smith, Paul R., Hiller, Louise, Szlosarek, Peter W., Kimberley, Christopher, Sehouli, Jalid, Koensgen, Dominique, Mustea, Alexander, Schmid, Peter and Crook, Tim. (2009) Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer. International Journal of Cancer, Vol.125 (No.6). pp. 1454-1463. ISSN 0020-7136

Earl, H. M., Vallier, A., Hiller, Louise, Fenwick, N., Iddawela, M., Hughes-Davies, L., Provenzano, E., McAdam, K., Hickish, T. and Caldas, C. (2009) Neo-tAnGo: a neoadjuvant randomized phase III trial of epirubicin/cyclophosphamide and paclitaxel +/- gemcitabine in the treatment of women with high-risk early breast cancer (EBC): first report of the primary endpoint, pathological complete response (pCR). In: 45th Annual Meeting of the American Society of Clinical Oncology, Orlando, FL, MAY 29-JUN 02, 2009. Published in: Journal of Clinical Oncology, Vol.27 (No.15 Suppl. S). Article: 522.

Bartlett, J. M. S., Munro, A., Dunn, Janet A., Hiller, Louise, Jordan, S., Twelves, C. J., Cameron, D. A., Thomas, J., Campbell, F., Rea, D. W., Provenzano, E., Pharoah, P., Caldas, C., Earl, H. and Poole, Christopher (2009) Chromosome 17 polysomy (Ch17) as a predictor of anthracycline response: emerging evidence from the UK NEA Tadjuvant breast cancer trial. In: 31st Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 10-14, 2008. Published in: Cancer Research, Vol.69 (No.2 Suppl. S). 74S-74S.

Pepper, Chris, Lin, Thet Thet, Pratt, Guy, Hewamana, Saman, Brennan, Paul , Hiller, Louise, Hills, R., Ward, Rachel, Starczynski, Jane, Austen, Belinda, Hooper, Laura, Stankovic, Tatjana and Fegan, Chris. (2008) Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. Blood, Vol.112 (No.9). pp. 3807-3817. ISSN 0006-4971

Behalf NEAT Investigators (Including: Earl, H. M., Hiller, Louise, Dunn, Janet A., Bathers, S., Harvey, P., Stanley, A., Grieve, R. J., Agrawal, R. K., Fernando, I. N., Brunt, A. M., McAdam, K., O'Reilly, S., Rea, D. W., Spooner, D. and Poole, Christopher). (2008) NEAT : national epirubicin adjuvant trial - toxicity, delivered dose intensity and quality of life. British Journal of Cancer, Vol.99 (No.8). pp. 1226-1231. ISSN 0007-0920

tAnGo Trial Collaborators (Including: Wardley, A. M., Hiller, Louise, Howard, H. C., Dunn, Janet A., Bowman, A., Coleman, R. E., Fernando, I. N., Ritchie, D. M., Earl, H. M. and Poole, Christopher). (2008) tAnGo : a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer : a prospective pulmonary, cardiac and hepatic function evaluation. British Journal of Cancer, Vol.99 (No.4). pp. 597-603. ISSN 0007-0920

Batta, K., Goodyear, H., Moss, C., Williams, H., Hiller, Louise and Waters, R. (2008) Randomized controlled study of early pulsed dye laser treatment of uncomplicated infantile haemangiomas: results of a 5-year analysis. In: 88th Annual Meeting of the British-Association-of-Dermatologists, Liverpool, England, Jul 01-04, 2008. Published in: British Journal of Dermatology, Vol.159 (Suppl. 1). p. 113.

Donnelly, Peter K., Hiller, Louise and Dunn, Janet A. (2008) Need for the iBreast trial – risk adjusted breast cancer follow-up trial. BMJ . ISSN 0959-535X

Donnelly, Peter K., Hiller, Louise and Dunn, Janet A. (2008) Follow-up after breast cancer : national randomised controlled trial is needed. British Medical Journal, Vol.336 (No.7642). pp. 461-462. ISSN 0959-8146

Tennant, Ruth, Hiller, Louise, Fishwick, Ruth, Platt, Stephen, Joseph, Stephen, Weich, Scott, Parkinson, Jane, Secker, Jenny and Stewart-Brown, Sarah L.. (2007) The Warwick-Edinburgh Mental Well-being Scale (WEMWBS) : development and UK validation. Health and Quality of Life Outcomes, Vol.5 (No.63). ISSN 1477-7525

Hiller, Louise, Bradshaw, H. D., Radley, S. C. and Radley, S.. (2007) Criterion validity of the BBUSQ-22: a questionnaire assessing bowel and urinary tract symptoms in women. International Urogynecology Journal, Vol.18 (No.10). pp. 1133-1137. ISSN 0937-3462

Bowden, S., Gross, L., Poole, C. J., Hiller, Louise, Agrawal, R. K., McAdam, K. F., Earl, H. M., Anwar, S. and Rea, D. (2007) NEAT-A: accelerated sequential epirubicin followed by higher dose 14 day CMF, using pegfilgrastim, is a feasible alternative for delivering dose dense E-CMF chemotherapy in early breast cancer. In: 14th European Cancer Conference (ECCO 14), Barcelona, Spain, SEP 23-27, 2007. Published in: European Journal of Cancer Supplements, Vol.5 (No.4). pp. 194-195.

Hiller, Louise, Fenwick, N., Vallier, A. L., Dunn, Janet A., Hilborne, S., Jones, L., Abraham, J., Iddawela, M., Caldas, C. and Earl, H. M. (2007) The challenges of using radiological 'tumour response' as an endpoint in Neo-tAnGo: a national neo-adjuvant chemotherapy breast cancer trial. In: 10th Nottingham International Breast Cancer Conference, Nottingham, England, September 18-20, 2007. Published in: European Journal of Cancer Supplements, Vol.5 (No.3). pp. 33-34.

Smith, Paul, Nicholson, Linda J., Syed, Nelofer, Payne, Annette, Hiller, Louise, Garrone, Ornella, Occelli, Marcella, Gasco, Milena and Crook, Tim. (2007) Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast cancer phenotypes. Clinical Cancer Research, Vol.13 (No.14). pp. 4061-4068. ISSN 1078-0432

Ainsworth, R., Dziedzic, K., Hiller, Louise, Daniels, J., Bruton, A. and Broadfield, J.. (2007) A prospective double blind placebo-controlled randomized trial of ultrasound in the physiotherapy treatment of shoulder pain. Rheumatology, Vol.46 (No.5). pp. 815-820. ISSN 1462-0324

Piper, M. K., Raza, K., Nuttall, S. L., Stevens, R., Toescu, V., Heaton, S., Gardner-Medwin, J., Hiller, Louise, Martin, U., Townend, J., Bacon, P. A. and Gordon, C.. (2007) Impaired endothelial function in systemic lupus erythematosus. Lupus, Vol.16 (No.2). pp. 84-88. ISSN 0961-2033

Ainsworth, R., Dziedzic, K., Hiller, Louise, Daniels, J., Bruton, A. and Broadfield, J. (2007) Comment on : a prospective double blind placebo-controlled randomized trial of ultrasound in the physiotherapy treatment of shoulder pain : reply. Rheumatology, Vol.47 (No.2). pp. 230-231. ISSN 1462-0324

. (2006) Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer. New England Journal of Medicine, Vol.355 (No.18). pp. 1851-1862. ISSN 0028-4793

Poole, C. J., Hiller, Louise, Howard, H. C., Loi, S., Dunn, Janet A., Canney, P., Wardley, A. M., Crown, J. P., Coleman, R. E., Verrill, M. W., Ellis, P. A., Leonard, R. C., Spooner, D. and Earl, H. M. (2006) Tolerability of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy in the randomized phase III tAnGo trial for invasive higher risk early stage breast cancer. In: 29th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, DEC 14-17, 2006. Published in: BREAST CANCER RESEARCH AND TREATMENT, 100 (Suppl. 1). S114-S114.